Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ABUS
#2454
Arbutus Biopharma Corporation - Common Stock
5.1
0
USD
-0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.35%
Monthly Change
+15.65%
6 month change
+12.33%
Year Change
+38.59%
Previous Close
5.1
7
Open
5.1
5
Low
5.0
9
High
5.1
5
Volume
488
Markets
US Stock Market
Healthcare
Biotechnology
ABUS
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2024
Quarterly report, Q2 FY2024
2024.08.08
Arbutus Biopharma Corp quarterly report, Q2 FY2024
10-Q
2010
Annual report, Q4 FY2010
2011.06.03
Arbutus Biopharma Corp annual report, Q4 FY2010
20-F
1
2
3
4
5
News
Why Is Arbutus Biopharma Stock Gaining Friday? - Arbutus Biopharma (NASDAQ:ABUS)
MRNA Q2 Earnings Meet, Stock Down on Norovirus Vaccine Setback
Arbutus Biopharma: A Fascinating HBV Story, But Still Too Early (NASDAQ:ABUS)
Moderna's Revenues See Strong International Momentum in Q1 Earnings
Moderna's Quarterly Earnings Preview: What You Need to Know
Moderna reaches $950 million settlement with Arbutus and Genevant over patent litigation
Why Moderna’s $950M Patent Bill Is A Small Price For Pipeline Freedom (NASDAQ:MRNA)
Chardan reiterates Arbutus Biopharma stock rating on Moderna deal
MRNA Stock Gains on $2.25B Deal to Settle Patent Dispute With ROIV, ABUS
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang
Moderna shares jump as settlement removes major legal overhang
Stock Market Today: Dow, Nasdaq Higher; Bitcoin Surges On Trump News (Live Coverage)